1,3-二氢-4-甲基-5-苯基-1-(苯基氨基)-2H-咪唑-2-硫酮 | 150093-92-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 1,3-二氢-4-甲基-5-苯基-1-(苯基氨基)-2H-咪唑-2-硫酮
• 英文名称: 4-methyl-5-phenyl-1-phenylamino-1H-imidazole-2-thione
• 英文别名: 3-anilino-5-methyl-4-phenyl-1H-imidazole-2-thione
• CAS: 150093-92-8
• 化学式: C₁₆H₁₅N₃S
• 分子量: 281.381
• InChiKey: QVTOWPPLGBQSQC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  59.4
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1,3-二氢-4-甲基-5-苯基-1-(苯基氨基)-2H-咪唑-2-硫酮 在 碘 、 sodium methylate 作用下， 以 甲醇 为溶剂， 反应 18.33h， 生成 4-methyl-5-phenyl-1-phenylamino-3-(β-D-ribofuranosyl)-1H-imidazole-2-thione
  参考文献：
  名称：

  Synthesis ofN-Substituted 1-Amino-2,3-dihydro-1H-imidazole-2-thione-N-nucleosides andS-Glycosylated Derivatives

  摘要：

  Fusion of the N-substituted 1-amino-2,3-dihydro-1H-imidazole-2-thiones 1-4 with the peracylated ribose 5 in the presence of iodine afforded the N-nucleosides 6-9 in moderate yields. Deblocking with NaOMe/MeOH gave the free nucleosides 10-13. Alternatively, silylation of 4 followed by ribosylation with 5 in the presence of TMSOTf as catalyst afforded 9 in moderate yield. Ribosylation of 4 with the chlorodeoxyribose derivative 15 as well as 5 in the presence of NaH in DMF afforded the thioglycosides 16 and 18, respectively. Deblocking of 16 and 18 with NaOMe/MeOH gave the free S-thioglycosides 17 and 19, respectively. Thermal rearrangement of 19 at high temperature in the presence of iodine furnished 13 in low yield. The new free nucleosides and thioglycosides were inactive against HIV-1 and HIV-2 induced cytopathicity in human MT-4 lymphocyte cells.

  DOI：

  10.1081/ncn-120021429
• 作为产物：
  描述：

  potassium thioacyanate 、 N-[[2-(N-aminoanilino)-1-phenylpropylidene]amino]aniline 在 溶剂黄146 作用下， 反应 0.17h， 以78%的产率得到1,3-二氢-4-甲基-5-苯基-1-(苯基氨基)-2H-咪唑-2-硫酮
  参考文献：
  名称：

  Addition products of hydrazine derivatives to azo-alkenes, part V: The reaction of ?-(1-phenylhydrazino)alkanone phyenylhydrazones with acids and acid derivatives

  摘要：

  The bifunctional title compounds 2 react with acylating, carbamoylating and sulfonylating reagents mostly at the primary amino group of the hydrazine function. Both functional groups of 2 are attacked by N,N'-carbonyldiimidazole converting it into 1H-1,2,4,5-tetrazepin-3-one derivatives 8. The acid-induced 1,4-elimination of phenylhydrazine from 2 gives rise to the formation of phenylosazones 3. In the presence of thiocyanic acid the intermediately formed phenylazo-alkenes 1 undergo [3 + 2]-cycloaddition furnishing 1-anilino-imidazoline-2-thiones 13.

  DOI：

  10.1007/bf00810587

文献信息

• Azodicarboxylates: valuable reagents for the multicomponent synthesis of novel 1,3,4-thiadiazoles and imidazo[2,1-b][1,3,4]thiadiazoles
  作者：Tryfon Zarganes-Tzitzikas、Constantinos G. Neochoritis、Julia Stephanidou-Stephanatou、Constantinos A. Tsoleridis、Gernot Buth、George E. Kostakis

  DOI：10.1016/j.tet.2013.03.096

  日期：2013.6

  5-thione substituent. The thiadiazoles became the only reaction products, formed in very good yield by using 2 equiv of azodicarboxylates. The sodium cyanoborohydride and sodium borohydride reductions to thiadiazoles 11, and 12 were also studied. Plausible mechanistic schemes for the formation of the thiadiazoles are proposed.

  在室温下在偶氮二羧酸盐（1.2当量）存在下，4,5-二取代-N-芳基氨基咪唑-2-硫酮与异氰酸酯反应，形成咪唑并[2,1- b ] [1,3,4]噻二唑唯一的反应产物收率很高，而通过使用更高的反应温度，连同咪唑并[2,1- b ] [1,3,4]噻二唑，也分离出了三组分反应产物，即噻二唑，形成取决于5-硫酮取代基。噻二唑成为唯一的反应产物，通过使用2当量的偶氮二羧酸盐以非常高的收率形成。氰基硼氢化钠和硼氢化钠还原为噻二唑11和12还进行了研究。提出了形成噻二唑的可行机理方案。
• A thorough study on the reaction of DMAD with 1-arylaminoimidazole-2-thiones. Expeditious synthesis of imidazo[2,1-b][1,3]thiazoles through a novel arylamino rearrangement
  作者：Constantinos Neochoritis、Nicolaos Eleftheriadis、Constantinos A. Tsoleridis、Julia Stephanidou-Stephanatou

  DOI：10.1016/j.tet.2009.11.056

  日期：2010.1

  Upon reaction of 1-arylamino-imidazole-2-thiones 1 with dimethyl acetylenedicarboxylate (DMAD) in the presence of 2.2 equiv of sodium hydride, imidazothiazoles 4 were exclusively formed (71–82% yield). However, from the reaction of 1 with DMAD in the absence of base, only the S-substituted products 5 were formed as an E/Z mixture (53–55%), which could also be converted to 4 with 2.0 equiv of sodium

  在存在2.2当量的氢化钠的情况下，使1-芳基氨基-咪唑-2-硫酮1与乙酰二羧酸二甲酯（DMAD）反应后，仅形成咪唑并噻唑4（产率为71–82％）。但是，从1与DMAD在不存在碱的情况下反应，仅形成S取代的产物5为E / Z混合物（53-55％），也可以用2.0当量的氢化钠将其转化为4（65–68％）。此外，将5a - E / Z转化为芳基氨基取代的衍生物8a与1.1当量的氢化钠反应后，产率为78％。在甲醇中存在甲醇钠的情况下，硫酮1a与DMAD的反应也可能形成8a（75％的收率）。通过用DMAD（91％）加热1a或加热苯中的5a - E / Z混合物（90％收率）观察到硫酮1a的咪唑3-NH取代生成6a - Z。最后，当5a - E与乙酸酐反应时，乙酰化衍生物7a - Z是唯一的分离产物（58％）。全部分配明确实现了1 H和13 C NMR化学位移。
• Hiv inhibiting n-aminoimidazole derivatives
  申请人：——

  公开号：US20040122024A1

  公开（公告）日：2004-06-24

  An N-aminoimidazole or N-aminoimidazolethione derivative, a pharmaceutically acceptable salt, a tautomer, an isomer, an ester or glycosylation product thereof, said derivative being represented by general formula (I): wherein m=zero or 1, n=zero or 1, R 1 is selected from hydrogen, methyl or ethyl, R 2 is selected from hydrogen, SH or —SR 0 wherein R 0 is methyl, benzyl or glucose residue; Q is selected from 1-naphtyl, 2-naphtyl, biphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidyl, 4-pyrimidyl, 5-pyrimidyl, thienyl, or a substituted or unsubstituted phenyl ring, wherein the substitution is understood as being one or two substituents selected from H, F, Cl, Br, I, methyl, ethyl or isopropyl; L is selected from 1-naphtyl, 2-naphtyl, biphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidyl, 4-pyrimidyl, 5-pyrimidyl, thienyl, or a substituted or unsubstituted phenyl ring wherein the substitution is understood as being one or two substituents selected from H, F, Cl, Br, I, methyl, ethyl or isopropyl. This invention further relates to the use of compounds of formula (I) as agents having biological activity, especially against viral infections.

  一种N-氨基咪唑或N-氨基咪唑硫醇衍生物，其药学上可接受的盐，互变异构体，异构体，酯或糖基化产物，所述衍生物由通式（I）表示： 其中m=0或1，n=0或1，R1选自氢，甲基或乙基，R2选自氢，SH或-SR0，其中R0为甲基，苄基或葡萄糖残基；Q选自1-萘基，2-萘基，联苯，2-吡啶基，3-吡啶基，4-吡啶基，2-嘧啶基，4-嘧啶基，5-嘧啶基，噻吩基或取代或未取代的苯环，其中取代被理解为是选择H，F，Cl，Br，I，甲基，乙基或异丙基中的一个或两个取代基；L选自1-萘基，2-萘基，联苯，2-吡啶基，3-吡啶基，4-吡啶基，2-嘧啶基，4-嘧啶基，5-嘧啶基，噻吩基或取代或未取代的苯环，其中取代被理解为是选择H，F，Cl，Br，I，甲基，乙基或异丙基中的一个或两个取代基。本发明还涉及将式（I）化合物作为具有生物活性的药物，特别是用于抗病毒感染。
• <i>N</i>-Aminoimidazole Derivatives Inhibiting Retroviral Replication via a Yet Unidentified Mode of Action
  作者：Irene M. Lagoja、Christophe Pannecouque、Arthur Van Aerschot、Myriam Witvrouw、Zeger Debyser、Jan Balzarini、Piet Herdewijn、Erik De Clercq

  DOI：10.1021/jm0211117

  日期：2003.4.1

  The synthesis of a series of N-aminoimidazoles (NAIMs) with an uncommon spectrum of antiretroviral activity is described. From a group of 60 closely related molecules, we were able to subdivide the molecules in different groups based on their anti-HIV and anti-SIV activity in vitro (i) molecules acting on a new, immediate postintegration step, (ii) molecules acting on both postintegration and HIV-1 reverse transcriptase (RT) as NNRTI, and (iii) molecules that mainly act at the HIV-1 RT according to an NNRTI-type mode of action.
• Direct Synthetic Approach to N-Substituted 1-Amino-2,3-dihydro-1H-imidazole-2-thiones
  作者：Joachim G. Schantl、Irene M. Lagoja

  DOI：10.3987/com-96-7715

  日期：——